Videos – Vogel Alcove
Impact and Programs: Vogel Alcove, a Dallas-based nonprofit, has served around 18,000 homeless children and families over 37 years, offering programs like early childhood education, health services, and mental health support to combat the traumatic effects of homelessness and poverty. Trauma-Responsive Care: In the podcast’s first episode, Vogel’s president Karen Hughes, along with Dr….
Latest
Articles
Empowering Through Connection: Vogel’s Pyramid Model Approach
Mission and Impact: Vogel Alcove, a nonprofit in Dallas, helps homeless children and families through various programs and services. Pyramid Model Framework: Vogel uses the Pyramid Model, an evidence-based framework for promoting young children’s social-emotional development with universal supports, targeted supports, and intensive interventions. Nurturing Relationships and Supportive Environments: Vogel focuses on building nurturing…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
